Overall Survival Prediction and Usefulness of Second-Line Chemotherapy in Advanced Pancreatic Adenocarcinoma
出版年份 2017 全文链接
标题
Overall Survival Prediction and Usefulness of Second-Line Chemotherapy in Advanced Pancreatic Adenocarcinoma
作者
关键词
-
出版物
JNCI-Journal of the National Cancer Institute
Volume 109, Issue 10, Pages -
出版商
Oxford University Press (OUP)
发表日期
2017-02-23
DOI
10.1093/jnci/djx037
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Second-line therapy after nab-paclitaxel plus gemcitabine or after gemcitabine for patients with metastatic pancreatic cancer
- (2016) E Gabriela Chiorean et al. BRITISH JOURNAL OF CANCER
- Prognostic nomogram and score to predict overall survival in locally advanced untreated pancreatic cancer (PROLAP)
- (2016) Dewi Vernerey et al. BRITISH JOURNAL OF CANCER
- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Prognostic value of health-related quality of life for overall survival in elderly non-small-cell lung cancer patients
- (2016) Frédéric Fiteni et al. EUROPEAN JOURNAL OF CANCER
- Metastatic Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline
- (2016) Davendra P.S. Sohal et al. JOURNAL OF CLINICAL ONCOLOGY
- Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial
- (2016) Andrea Wang-Gillam et al. LANCET
- Second-Line Treatment in Pancreatic Cancer Patients
- (2016) Marianne Sinn et al. PANCREAS
- Prognostic Scoring Index for Patients with Metastatic Pancreatic Adenocarcinoma
- (2016) Hyung Soon Park et al. Cancer Research and Treatment
- Prognostic value of health-related quality of life for death risk stratification in patients with unresectable glioblastoma
- (2016) Brice Paquette et al. Cancer Medicine
- Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
- (2015) Karel G.M. Moons et al. ANNALS OF INTERNAL MEDICINE
- Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2015) M. Ducreux et al. ANNALS OF ONCOLOGY
- Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): The TRIPOD statement
- (2015) G S Collins et al. BRITISH JOURNAL OF CANCER
- Nab-paclitaxel plus gemcitabine for metastatic pancreatic adenocarcinoma after Folfirinox failure: an AGEO prospective multicentre cohort
- (2015) Alix Portal et al. BRITISH JOURNAL OF CANCER
- Decision Curve Analysis
- (2015) Mark Fitzgerald et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Randomized, Double-Blind, Phase II Study of Ruxolitinib or Placebo in Combination With Capecitabine in Patients With Metastatic Pancreatic Cancer for Whom Therapy With Gemcitabine Has Failed
- (2015) Herbert I. Hurwitz et al. JOURNAL OF CLINICAL ONCOLOGY
- Nomograms in oncology: more than meets the eye
- (2015) Vinod P Balachandran et al. LANCET ONCOLOGY
- Impact of Smoking on Pancreatic Cancer Patients Receiving Current Chemotherapy
- (2015) Chihiro Kawaguchi et al. PANCREAS
- State of the art and future directions of pancreatic ductal adenocarcinoma therapy
- (2015) Cindy Neuzillet et al. PHARMACOLOGY & THERAPEUTICS
- Prognostic value of health-related quality of life in patients with metastatic pancreatic adenocarcinoma: a random forest methodology
- (2015) Momar Diouf et al. QUALITY OF LIFE RESEARCH
- Pancreatic Adenocarcinoma
- (2015) David P. Ryan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
- (2014) L. Rahib et al. CANCER RESEARCH
- Could baseline health-related quality of life (QoL) predict overall survival in metastatic colorectal cancer? The results of the GERCOR OPTIMOX 1 study
- (2014) Momar Diouf et al. Health and Quality of Life Outcomes
- Second-Line Oxaliplatin, Folinic Acid, and Fluorouracil Versus Folinic Acid and Fluorouracil Alone for Gemcitabine-Refractory Pancreatic Cancer: Outcomes From the CONKO-003 Trial
- (2014) Helmut Oettle et al. JOURNAL OF CLINICAL ONCOLOGY
- Beyond first-line chemotherapy for advanced pancreatic cancer: An expanding array of therapeutic options?
- (2014) Evan J Walker WORLD JOURNAL OF GASTROENTEROLOGY
- Second-line treatment in advanced pancreatic cancer: a comprehensive analysis of published clinical trials
- (2013) O. E. Rahma et al. ANNALS OF ONCOLOGY
- Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
- (2013) Daniel D. Von Hoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impact of FOLFIRINOX Compared With Gemcitabine on Quality of Life in Patients With Metastatic Pancreatic Cancer: Results From the PRODIGE 4/ACCORD 11 Randomized Trial
- (2012) Sophie Gourgou-Bourgade et al. JOURNAL OF CLINICAL ONCOLOGY
- Cigarette smoking and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (Panc4)
- (2011) C. Bosetti et al. ANNALS OF ONCOLOGY
- A Prognostic Model to Identify Patients with Advanced Pancreas Adenocarcinoma Who Could Benefit from Second-line Chemotherapy
- (2011) Seung Tae Kim et al. CLINICAL ONCOLOGY
- Best supportive care (BSC) versus oxaliplatin, folinic acid and 5-fluorouracil (OFF) plus BSC in patients for second-line advanced pancreatic cancer: A phase III-study from the German CONKO-study group
- (2011) Uwe Pelzer et al. EUROPEAN JOURNAL OF CANCER
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
- (2011) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search